Ardent Health, Inc.·4

Apr 2, 4:51 PM ET

Bulgarelli Peter J. 4

Research Summary

AI-generated summary

Updated

Ardent Health (ARDT) Director Peter Bulgarelli Receives Restricted Award

What Happened

Peter J. Bulgarelli, a director of Ardent Health, Inc. (ARDT), received an award of 14,231 restricted stock units (RSUs) on April 1, 2026. The reported acquisition price is $0.00, reflecting a grant rather than a cash purchase. These RSUs represent a promise to deliver shares if vesting conditions are met; they are not an immediate sale or purchase of open-market shares.

Key Details

  • Transaction date: 2026-04-01 (reported on Form 4 filed 2026-04-02).
  • Transaction type/code: Award/Grant (A). Price reported: $0.00.
  • Shares/units granted: 14,231 RSUs.
  • Vesting: RSUs vest in full on the first anniversary of April 1, 2026 (vesting date: 2027-04-01), subject to continued service (per footnote).
  • Shares owned after transaction: Not disclosed in the provided filing excerpt.
  • Timeliness: Filing appears timely (transaction 2026-04-01; Form 4 filed 2026-04-02).

Context

  • RSUs are a form of deferred equity compensation; no shares are delivered until vesting conditions are met. Reporting $0.00 for the award is typical for grants (no cash exchanged at grant).
  • This is a grant/compensation event (not a market buy or sale) and does not by itself indicate immediate buying or selling activity.